AI Just Found a Lung Cancer Drug and Cracked a 100-Year-Old Chemistry Problem
Researchers say artificial intelligence systems have discovered a promising new lung cancer drug and solved a decades-old challenge in drug manufacturing, signaling a major shift in how medicines are developed.
A team of artificial intelligence (AI) systems has discovered a promising new drug for lung cancer, according to researchers behind the project. The AI systems worked together to find the drug, a departure from the usual method where human scientists do most of the work. Lung cancer is one of the most common and deadly cancers worldwide, and new treatments are badly needed. The researchers say the AI-discovered drug could lead to a new therapy, though more testing is required. The team believes this shows how AI can speed up drug discovery, which normally takes many years and costs a lot of money [1].
In a separate breakthrough, chemists have reported that AI can now work out how to make molecules by thinking backwards—a process called retrosynthesis. This involves starting from a target molecule and working backwards to find the ingredients and steps needed to build it. For decades, this has been one of the slowest and most expensive parts of drug discovery, with human experts sometimes taking weeks to plan a single route [2].
The new approach combines several different AI models into one team, each bringing its own strengths. A voting system then picks the best route. Crucially, the system is "chemist-aligned"—meaning it produces routes that a real chemist would accept as safe, practical, and buildable in a real laboratory. The researchers report that this ensemble method outperforms single models on standard tests, finding more correct routes and ranking them higher [2].
The impact could be large. Faster retrosynthesis means faster drug development, cheaper chemicals, and quicker responses to new diseases. The paper's authors suggest their method could become a standard tool in both industry and academia. For now, the work is a proof of concept, but it points to a future where a chemist types in a molecule and, within minutes, receives a workable plan to make it [2].
Together, these developments suggest AI is moving from a supporting role in science to a leading one. The lung cancer drug discovery shows AI can identify new treatments, while the retrosynthesis breakthrough shows it can figure out how to manufacture them. Both developments could accelerate the pace of medical innovation in ways that were not possible before [1][2].